| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/11/2003 | US20030228620 Nested PCR employing degradable primers |
| 12/11/2003 | US20030228619 Using labeled peptidic nucleotide sequences to screen coded synthetic libraries for non-linear, non-polymeric, heterocyclic molecules |
| 12/11/2003 | US20030228618 Screening sample of nucleotide sequences for naturally occuring oligonucleotide associated with gene expression inhibition and modulation; drug screening; genetic mapping; tumor diagnosis |
| 12/11/2003 | US20030228617 Method for predicting autoimmune diseases |
| 12/11/2003 | US20030228615 Method for identifying accessible binding sites on RNA |
| 12/11/2003 | US20030228614 Measuring levels of metabolites 3-OH-3-methylindolenine, 3-methyloxindole, indole-3-carbinol, and 2-aminoacetophenone in a pig may be useful in identifying the pig's ability to metabolize skatole and its susceptibility to boar taint |
| 12/11/2003 | US20030228613 Nucleic acid amplification |
| 12/11/2003 | US20030228611 Nucleic acid memory device |
| 12/11/2003 | US20030228610 Encoded beads having oligonucleotides attached and formed in arrays |
| 12/11/2003 | US20030228609 Methods for measuring enzyme activity |
| 12/11/2003 | US20030228608 Targeting and altering preselected target nucleic acid sequence using recombinases and extrachromaosomal nucleotide sequences; genetic engineering |
| 12/11/2003 | US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 12/11/2003 | US20030228604 System for tracing animal products |
| 12/11/2003 | US20030228603 Diagnostic probes for detecting caffeine and/or aspartame in beverages |
| 12/11/2003 | US20030228601 Identifying nucleotide sequences capable of post-transcriptional gene silencing; regulatory sequences; transcriptional profiling; high throughput assays |
| 12/11/2003 | US20030228599 Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms |
| 12/11/2003 | US20030228597 Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation |
| 12/11/2003 | US20030228596 A truncated amplification (TA) for achieving high accuracy nucleic acid amplification, utilizes oligonucleotide primers and thermal cycling, but differs from polymerase chain reaction; three round of replication from original templates |
| 12/11/2003 | US20030228594 Digesting a target nucleic acid molecule; capturing digested fragments on a solid support that containing oligonucleotides complementary, detecting hybrids and molecular weight of captured fragments by mass spectrometry to identify mutations |
| 12/11/2003 | US20030228591 Methods for searching polynucleotide probe targets in databases |
| 12/11/2003 | US20030228590 Antibodies having specificity for nucleic acids |
| 12/11/2003 | US20030228589 Incubating the composition containing a target nucleic acid template, a primer, an extendable nucleotide, and thermus thermophilus GK24 and thermus oshimai(G43D, F665Y) under appropriate conditions to generate primer extension product |
| 12/11/2003 | US20030228586 Method for measuring de novo T-cell production in humans |
| 12/11/2003 | US20030228585 Human Leukocyte Antigen (HLA); hybridization between a nucleic acid sequence derived from the test specimen and oligonucleotides |
| 12/11/2003 | US20030228582 Genotyping individuals for allele of eicosanoid; use in determining the genetic predisposition of individuals to diseases and in predicting responses to drugs |
| 12/11/2003 | US20030228581 Comparing the nucleotide sequence encoding the AIF protein from a human biopsy to a wild-type |
| 12/11/2003 | US20030228580 Method for enhancing DNA base-calling accuracy |
| 12/11/2003 | US20030228578 Alternative splicing and nonsense-mediated decay: computational methods and gene regulation |
| 12/11/2003 | US20030228575 Combination of circulating epstein-barr virus (EBV) DNA in the serum or plasma of patients and a method to assess EBV subtypes for the prediction and detection of epstein-barr virus associated cancers |
| 12/11/2003 | US20030228574 Amplification of HIV-1 sequences for detection of sequences associated with drug-resistance mutations |
| 12/11/2003 | US20030228573 Contacting test compound with Gag283 and determining its ability to bind to the apical cleft near the C-terminal domain; use in treatment of Acquired Immunodeficiency Syndrome (AIDS) |
| 12/11/2003 | US20030228572 Method of determining the efficacy of a compound in treating microbial infection |
| 12/11/2003 | US20030228571 Nucleic acid amplification and molecular weight determination using primers which hybridize to conserved sequence regions from the pathogen; base composition is matched against a database |
| 12/11/2003 | US20030228570 Methods of diagnosis of Hepatitis C infection, compositions and methods of screening for modulators of Hepatitis C infection |
| 12/11/2003 | US20030228568 Inducible phosphofructokinase and the warburg effect |
| 12/11/2003 | US20030228371 Anti-infarction molecules |
| 12/11/2003 | US20030228329 Genetic engineering; insertion of gene; generating immunology response |
| 12/11/2003 | US20030228308 Immunology active materials; complexing; anticancer agents |
| 12/11/2003 | US20030228261 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/11/2003 | US20030228260 Drug delivery; central nervous system disorders |
| 12/11/2003 | US20030228259 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products |
| 12/11/2003 | US20030226963 System and method for the preparation of arrays of biological or other molecules |
| 12/11/2003 | US20030226768 Method for detecting macromolecular biopolymers by means of an electrode arrangement |
| 12/11/2003 | US20030226755 Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis |
| 12/11/2003 | US20030226753 Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis |
| 12/11/2003 | CA2510406A1 Method of detecting gene polymorphism |
| 12/11/2003 | CA2493863A1 Arrays identifying genomic and proteomic biomarkers for cystic fibrosis |
| 12/11/2003 | CA2492631A1 Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood |
| 12/11/2003 | CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | CA2488568A1 Methods of diagnosing and treating diabetes and insulin resistance |
| 12/11/2003 | CA2488547A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/11/2003 | CA2488539A1 Novel proteins and nucleic acids encoding same |
| 12/11/2003 | CA2488284A1 Cancer-linked gene as target for chemotherapy |
| 12/11/2003 | CA2488048A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | CA2488012A1 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | CA2488006A1 A human cell assay to determine effect of sample compounds on col2 enhancer expression |
| 12/11/2003 | CA2487954A1 Methods of detecting target molecules and molecular interactions |
| 12/11/2003 | CA2487939A1 Semaphorin-like proteins and methods of using same |
| 12/11/2003 | CA2487936A1 Method for high-throughput integrated chemical and biochemical reactions |
| 12/11/2003 | CA2487933A1 Novel high density arrays and methods for analyte analysis |
| 12/11/2003 | CA2487929A1 High throughput cellular response assay using microarrays |
| 12/11/2003 | CA2487928A1 Pthrp-based prediction and diagnosis of bone disease |
| 12/11/2003 | CA2487915A1 Allergen from mugwort pollen |
| 12/11/2003 | CA2487895A1 Defensins: use as antiviral agents |
| 12/11/2003 | CA2487792A1 Device and method of use for detection and characterization of pathogens and biological materials |
| 12/11/2003 | CA2487765A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 12/11/2003 | CA2487730A1 Sgk and nedd used as diagnostic and therapeutic targets |
| 12/11/2003 | CA2487724A1 Immunogenic sequences |
| 12/11/2003 | CA2487660A1 Methods for improving rna transcription reactions |
| 12/11/2003 | CA2487534A1 Method for parallelly sequencing a nucleic acid mixture by using a continuous flow system |
| 12/11/2003 | CA2487527A1 Method of typing gene polymorphisms |
| 12/11/2003 | CA2487513A1 Improved receptor detection |
| 12/11/2003 | CA2487314A1 Methods for quantitative proteome analysis of glycoproteins |
| 12/11/2003 | CA2487024A1 Control sequences of the human corin gene |
| 12/11/2003 | CA2486658A1 Method for efficient rna interference in mammalian cells |
| 12/11/2003 | CA2486616A1 Methods, compositions and kits for cell separation |
| 12/11/2003 | CA2485653A1 Human 5-ht7 receptor promoter sequence |
| 12/11/2003 | CA2485411A1 Direct pcr quantification |
| 12/11/2003 | CA2485203A1 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants |
| 12/11/2003 | CA2483872A1 Proteins and methods useful for assessing risk of cardiovascular disease |
| 12/11/2003 | CA2482957A1 Assay for glycosylated proteins |
| 12/11/2003 | CA2480326A1 Knockout mice and their use |
| 12/10/2003 | EP1369695A1 Method for identifying type-I interferon responsive MS patients by determining TRAIL expression |
| 12/10/2003 | EP1369694A1 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 12/10/2003 | EP1369691A1 Device and method utilizing arrays of structures for analyte capture |
| 12/10/2003 | EP1369687A1 Biosensor |
| 12/10/2003 | EP1369684A1 Quantitative analyzing method and quantitative analyzer using sensor |
| 12/10/2003 | EP1369496A2 Method of making random array of microspheres using enzyme digestion |
| 12/10/2003 | EP1369495A1 Probes for detecting and identifying helicobacter pylori |
| 12/10/2003 | EP1369494A2 Method for ordering macromolecules by means of a moving meniscus and uses thereof |
| 12/10/2003 | EP1369493A1 Quantitative determination method for the degree of methylation of cytosines in CpG positions |
| 12/10/2003 | EP1369492A1 Detection of staphylococcus spp |
| 12/10/2003 | EP1369491A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/10/2003 | EP1369485A1 Glucose dehydrogenase |
| 12/10/2003 | EP1369483A1 Allergen from mugwort pollen |
| 12/10/2003 | EP1369477A1 METHOD OF CONSTRUCTING cDNA TAG FOR IDENTIFYING EXPRESSED GENE AND METHOD OF ANALYZING GENE EXPRESSION |
| 12/10/2003 | EP1369430A2 Two human G-Protein coupled receptors: EBV-induced GPCR 2(EBI-2) and EBG-1-like GPCR |
| 12/10/2003 | EP1369427A2 HIV-3 retrovirus strains and their use |
| 12/10/2003 | EP1368662A2 Method for detection of the presence of prion proteins |
| 12/10/2003 | EP1368660A2 Assay |